
Lyndra Therapeutics (Formerly Lyndra)
The first-ever oral, ultra-long-acting, sustained release therapies, which enables patients to take a pill once a week rather than daily.
Employees
Enterprise value
$404—606m
Authorizing premium user...
The first-ever oral, ultra-long-acting, sustained release therapies, which enables patients to take a pill once a week rather than daily.